1. Caballero B (2007) The Global Epidemic of Obesity: An Overview. Epidemiologic Reviews 29: 1-5.
2. Martel J, Ojcius D, Chang CJ, Lin CS, Lu CC, et al. (2016) Anti-obesogenic and antidiabetic effects of plants and mushrooms.
3. Mcardle M, Finucane O, Connaughton R, Mcmorrow A, Roche H (2013) Mechanisms of Obesity-Induced Inflammation and Insulin Resistance: Insights into the Emerging Role of Nutritional Strategies. Frontiers in Endocrinology: 4.
4. Haslam DW, James WPT (2002) Obesity. The Lancet 366: 1197-209.
5. Visscher TL, Seidell JC (2001) The Public Health Impact of Obesity. Annual Review of Public Health, 22: 355-75.
6. Pi-Sunyer X (2009) The Medical Risks of Obesity. Postgraduate medicine, 121: 21-33.
7. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, et al. (2009) The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis. BMC Public Health 9: 88.
8. Wing RR, Lang W, Wadden TA, Safford M, Knowler WC, et al. (2011) Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes. Diabetes Care 34: 1481-6.
9. Yanovski SZ, Yanovski JA (2014) Long-term Drug Treatment for Obesity: A Systematic and Clinical Review. JAMA 311: 74-86.
10. Bult MJF, Van Dalen T, Muller AF (2008) Surgical treatment of obesity. European Journal of Endocrinology, 158: 135-45.
11. Dietrich, M. O. & Horvath, T. L. (2012). Limitations in anti-obesity drug development: the critical role of hunger-promoting neurons. Nat Rev Drug Discov 11: 675-91.
12. Field BCT, Chaudhri OB, Bloom SR (2009) Obesity treatment: novel peripheral targets. British J Clin Pharmacol 68: 830-43.
13. Prasad-Reddy L, Isaacs D (2015) A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond. Drugs in Context 4: 212283.
14. Elangbam CS (2009) Review paper: Current strategies in the development of anti-obesity drugs and their safety concerns. Vet Pathol, 46: 10-24.
15. Kaila B, Raman M (2008) Obesity: a review of pathogenesis and management strategies. Can J Gastroenterol, 22: 61-8.
16. Lunagariya NA, Patel NK, Jagtap SC, Bhutani KK (2014) Inhibitors of pancreatic lipase: state of the art and clinical perspectives. EXCLI J 13: 897-921.
17. Lam DD, Przydzial MJ, Ridley SH, Yeo GSH, Rochford JJ, et al. (2008). Serotonin 5-HT2C Receptor Agonist Promotes Hypophagia via Downstream Activation of Melanocortin 4 Receptors. Endocrinology 149: 1323-8.
18. Birari RB, Bhutani KK (2007) Pancreatic lipase inhibitors from natural sources: unexplored potential. Drug Discovery Today 12: 879-89.
19. Hamdan I, Kasabri V, Alhiari Y, El-sabawi D, Zalloum H (2018) Pancreatic Lipase Inhibitory Activity Of Selected Pharmaceutical Agents. Acta Pharmaceutica: 69.
20. Chen T, Li Y, Zhang L (2017) Nine Different Chemical Species and Action Mechanisms of Pancreatic Lipase Ligands Screened Out from Forsythia suspensa Leaves All at One Time. Molecules 22: 795. 
21. Constantinou-Kokotou V, Magrioti V, Verger R (2004) Sterically Hindered Triacylglycerol Analogues as Potent Inhibitors of Human Digestive Lipases. Chemistry – A European J 10: 1133-40. 
22. Birari RB, Gupta S, Mohan SG (2011) Antiobesity and lipid lowering effects of Glycyrrhiza chalcones: Experimental and computational studies. Phytomedicine, 18: 795-801.
23. Lee EM, Lee S, Chung B, Cho JY, Lee I, et al. (2010) Pancreatic Lipase Inhibition by C-Glycosidic Flavones Isolated from Eremochloa ophiuroides. Molecules (Basel, Switzerland) 15: 8251-9.
24. Lunagariya NA, Patel NK, Jagtap SC, Bhutani KK (2014) Inhibitors of pancreatic lipase: state of the art and clinical perspectives. Excli J 13: 897-921.
25. Matsumoto M, Hosokawa M, Matsukawa N, Hagio M, et al. (2010) Suppressive effects of the marine carotenoids, fucoxanthin and fucoxanthinol on triglyceride absorption in lymph duct-cannulated rats. European J Nutri 49: 243-49.
26. Sumiyoshi M, Kimura Y (2006) Low molecular weight chitosan inhibits obesity induced by feeding a high-fat diet long-term in mice. J Pharmacology 58: 201-7.
27. Gras J (2013) Cetilistat for the treatment of obesity. Drugs of today (Barcelona, Spain: 1998) 49: 755-9.
28. Kumar D, Karmase A, Jagtap S, Shekhar R, Bhutani K (2013) Pancreatic Lipase Inhibitory Activity of Cassiamin A, a Bianthraquinone from Cassia siamea. Natural product communications 8: 195-8.